J Eur Acad Dermatol Venereol
April 2022
Background: The long-term evolution of children with segmental facial infantile haemangioma (SFIH) treated with propranolol remains unstudied.
Objectives: The objective of this study was to evaluate the neurodevelopmental features of children with SFIH treated with propranolol at 6 years of age.
Methods: This retrospective case series study was conducted from January 2008 to June 2020 using data from medical files, patient examinations and appointments spanning 6 years.